On May 12, 2025, the Trump Administration published Executive Order 14297, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” which generally, among other things, directs the federal government to establish and communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations.
All entries for: Agomab Therapeutics NV
April 23, 2026
Agomab Therapeutics NV
Neutral Outlook
Antwerpen, Belgium
51-200 employees
Thus, while it is unclear how the IRA will be implemented, it will likely have a significant impact on the pharmaceutical industry.
Disease Area: Gastrointestinal, Respiratory Diseases
Drug Type: Small Molecule